2 000 doses of Tocilizumab produced by Hetero Biopharma Limited and Roche monoclonal antibodies - 500 doses of Ronapreve (Casirivimab/ Imdevimab) are already in Georgia.

According to the Ministry of Health, Hetero Biopharma Limited is one of the leading Indian pharmaceutical companies that received authorization for emergency use of Tocilizumab at the end of September this year.

Georgia first received Roche monoclonal antibodies as a donation from Germany. Roche monoclonal antibodies have been authorized by the US Food and Drug Administration for emergency use.